VIJAYA1,503.00

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,465 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
VIJAYA
FY26
THYROCARE
FY26
METROPOLIS
FY26
LALPATHLAB
FY26
Peer
Median
Valuation — at last close
P/E89.41×54.33×64.74×63.23×63.23× +41%
P/B16.16×15.15×8.09×12.61×12.61× +28%
EV/EBITDA45.10×33.17×30.33×40.10×33.17× +36%
Market Cap₹15,465 Cr₹8,882 Cr₹12,336 Cr₹32,045 Cr₹12,336 Cr +25%
Growth
Revenue CAGR 3Y21.03%16.33%12.75%11.06%12.75% +65%
Revenue CAGR 5Y16.66%10.88%10.52%11.81%10.88% +53%
Net Income CAGR 3Y26.62%36.27%10.06%28.35%28.35% -6%
Revenue YoY (latest Q)22.83%24.34%16.62%19.10%19.10% +20%
Net Income YoY (latest Q)37.61%34.06%25.72%27.24%27.24% +38%
Profitability
EBITDA Margin41.38%31.61%24.36%28.32%28.32% +46%
Net Income Margin21.24%19.64%11.62%18.45%18.45% +15%
Return on Common Equity18.07%27.82%12.46%19.86%19.86% -9%
Return on Capital Employed17.72%31.92%14.81%23.03%23.03% -23%
Return on Assets11.48%21.79%8.94%16.20%16.20% -29%
Credit & Quality
Total Debt/Equity0.00×0.00×0.01×0.00×0.00×
Interest Coverage7.38×72.66×10.88×27.22×27.22× -73%
Scale — latest FY
Revenue / Total Income₹814 Cr₹829 Cr₹1,646 Cr₹2,763 Cr₹1,646 Cr -51%
Net Income₹173 Cr₹163 Cr₹191 Cr₹510 Cr₹191 Cr -10%
Total Assets₹1,507 Cr₹747 Cr₹2,138 Cr₹3,146 Cr₹2,138 Cr -30%
EPS₹16.81₹10.27₹9.19₹30.24₹10.27 +64%
Book Value per Share₹93.02₹36.82₹73.53₹151.63₹73.53 +27%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.